Rank | Gene Set | Z-score |
---|---|---|
1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.87905311 |
2 | L-phenylalanine catabolic process (GO:0006559) | 6.87905311 |
3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.74021860 |
4 | L-phenylalanine metabolic process (GO:0006558) | 6.74021860 |
5 | aromatic amino acid family catabolic process (GO:0009074) | 5.95965236 |
6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.75008946 |
7 | alpha-linolenic acid metabolic process (GO:0036109) | 5.63933342 |
8 | kynurenine metabolic process (GO:0070189) | 5.38283095 |
9 | glyoxylate metabolic process (GO:0046487) | 5.34720538 |
10 | indole-containing compound catabolic process (GO:0042436) | 5.23249836 |
11 | indolalkylamine catabolic process (GO:0046218) | 5.23249836 |
12 | tryptophan catabolic process (GO:0006569) | 5.23249836 |
13 | bile acid biosynthetic process (GO:0006699) | 5.21443887 |
14 | sulfur amino acid catabolic process (GO:0000098) | 5.19678303 |
15 | lysine catabolic process (GO:0006554) | 5.17164115 |
16 | lysine metabolic process (GO:0006553) | 5.17164115 |
17 | cysteine metabolic process (GO:0006534) | 5.11791815 |
18 | urea cycle (GO:0000050) | 5.02859532 |
19 | urea metabolic process (GO:0019627) | 5.02859532 |
20 | negative regulation of fibrinolysis (GO:0051918) | 4.94735812 |
21 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.91212594 |
22 | tryptophan metabolic process (GO:0006568) | 4.87939227 |
23 | high-density lipoprotein particle remodeling (GO:0034375) | 4.79290699 |
24 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.76795618 |
25 | complement activation, alternative pathway (GO:0006957) | 4.74991298 |
26 | regulation of triglyceride catabolic process (GO:0010896) | 4.69470406 |
27 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.67332787 |
28 | protein carboxylation (GO:0018214) | 4.67332787 |
29 | nitrogen cycle metabolic process (GO:0071941) | 4.61050144 |
30 | regulation of protein activation cascade (GO:2000257) | 4.60157987 |
31 | serine family amino acid catabolic process (GO:0009071) | 4.54203075 |
32 | regulation of fibrinolysis (GO:0051917) | 4.53354660 |
33 | amino-acid betaine metabolic process (GO:0006577) | 4.49940784 |
34 | bile acid metabolic process (GO:0008206) | 4.45125632 |
35 | negative regulation of sterol transport (GO:0032372) | 4.39508030 |
36 | negative regulation of cholesterol transport (GO:0032375) | 4.39508030 |
37 | homocysteine metabolic process (GO:0050667) | 4.33983360 |
38 | regulation of complement activation (GO:0030449) | 4.32170773 |
39 | aromatic amino acid family metabolic process (GO:0009072) | 4.29502756 |
40 | regulation of cholesterol homeostasis (GO:2000188) | 4.28866658 |
41 | alpha-amino acid catabolic process (GO:1901606) | 4.27642337 |
42 | reverse cholesterol transport (GO:0043691) | 4.23622651 |
43 | ethanol oxidation (GO:0006069) | 4.21130913 |
44 | glutamate metabolic process (GO:0006536) | 4.21090004 |
45 | regulation of cholesterol esterification (GO:0010872) | 4.15990077 |
46 | acylglycerol homeostasis (GO:0055090) | 4.12830945 |
47 | triglyceride homeostasis (GO:0070328) | 4.12830945 |
48 | tyrosine metabolic process (GO:0006570) | 4.12568466 |
49 | protein-lipid complex remodeling (GO:0034368) | 4.11350553 |
50 | macromolecular complex remodeling (GO:0034367) | 4.11350553 |
51 | plasma lipoprotein particle remodeling (GO:0034369) | 4.11350553 |
52 | 2-oxoglutarate metabolic process (GO:0006103) | 4.10716633 |
53 | plasma lipoprotein particle clearance (GO:0034381) | 4.09729498 |
54 | cellular ketone body metabolic process (GO:0046950) | 4.07767022 |
55 | cellular modified amino acid catabolic process (GO:0042219) | 4.03222418 |
56 | cellular amino acid catabolic process (GO:0009063) | 4.02513892 |
57 | acetyl-CoA metabolic process (GO:0006084) | 4.00445417 |
58 | phospholipid efflux (GO:0033700) | 4.00216956 |
59 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.98053109 |
60 | glycine metabolic process (GO:0006544) | 3.96350860 |
61 | short-chain fatty acid metabolic process (GO:0046459) | 3.93304995 |
62 | coenzyme catabolic process (GO:0009109) | 3.92589512 |
63 | aspartate family amino acid catabolic process (GO:0009068) | 3.90189640 |
64 | mannose metabolic process (GO:0006013) | 3.89252318 |
65 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.88494919 |
66 | fatty acid beta-oxidation (GO:0006635) | 3.84627644 |
67 | serine family amino acid metabolic process (GO:0009069) | 3.79946131 |
68 | drug catabolic process (GO:0042737) | 3.77315105 |
69 | fatty acid oxidation (GO:0019395) | 3.74944954 |
70 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.74741425 |
71 | positive regulation of lipid catabolic process (GO:0050996) | 3.74536845 |
72 | valine metabolic process (GO:0006573) | 3.68200934 |
73 | lipid oxidation (GO:0034440) | 3.66696799 |
74 | fatty acid catabolic process (GO:0009062) | 3.66102706 |
75 | monocarboxylic acid catabolic process (GO:0072329) | 3.65568696 |
76 | organic acid catabolic process (GO:0016054) | 3.64434877 |
77 | carboxylic acid catabolic process (GO:0046395) | 3.64434877 |
78 | plasma lipoprotein particle assembly (GO:0034377) | 3.63814129 |
79 | bile acid and bile salt transport (GO:0015721) | 3.63696514 |
80 | Golgi transport vesicle coating (GO:0048200) | 3.62865311 |
81 | COPI coating of Golgi vesicle (GO:0048205) | 3.62865311 |
82 | benzene-containing compound metabolic process (GO:0042537) | 3.62146968 |
83 | indolalkylamine metabolic process (GO:0006586) | 3.58321738 |
84 | cholesterol efflux (GO:0033344) | 3.57931907 |
85 | negative regulation of lipase activity (GO:0060192) | 3.56736230 |
86 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.55401363 |
87 | drug transmembrane transport (GO:0006855) | 3.52356428 |
88 | carnitine metabolic process (GO:0009437) | 3.51999283 |
89 | ketone body metabolic process (GO:1902224) | 3.51815726 |
90 | imidazole-containing compound metabolic process (GO:0052803) | 3.50032828 |
91 | phospholipid homeostasis (GO:0055091) | 3.50008938 |
92 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.47306914 |
93 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.47306914 |
94 | serine family amino acid biosynthetic process (GO:0009070) | 3.46109418 |
95 | arginine metabolic process (GO:0006525) | 3.43274821 |
96 | cholesterol homeostasis (GO:0042632) | 3.42794717 |
97 | protein-lipid complex assembly (GO:0065005) | 3.41556979 |
98 | regulation of cholesterol metabolic process (GO:0090181) | 3.40819265 |
99 | sterol homeostasis (GO:0055092) | 3.38103562 |
100 | complement activation, classical pathway (GO:0006958) | 3.35668677 |
101 | amine catabolic process (GO:0009310) | 3.35405995 |
102 | cellular biogenic amine catabolic process (GO:0042402) | 3.35405995 |
103 | cellular glucuronidation (GO:0052695) | 3.34652765 |
104 | fatty acid transmembrane transport (GO:1902001) | 3.32454185 |
105 | regulation of ARF protein signal transduction (GO:0032012) | 3.26212566 |
106 | negative regulation of cell size (GO:0045792) | 3.25349479 |
107 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.22474681 |
108 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.15170134 |
109 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.15047214 |
110 | regulation of extracellular matrix disassembly (GO:0010715) | 3.14342057 |
111 | regulation of ARF GTPase activity (GO:0032312) | 3.10432032 |
112 | proline biosynthetic process (GO:0006561) | 3.10369703 |
113 | protein retention in ER lumen (GO:0006621) | 3.08359431 |
114 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.05450961 |
115 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.04934093 |
116 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.04933530 |
117 | proline metabolic process (GO:0006560) | 2.92599817 |
118 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.91893648 |
119 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.88836154 |
120 | ethanol metabolic process (GO:0006067) | 2.85946007 |
121 | detection of bacterium (GO:0016045) | 2.85784876 |
122 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.84135000 |
123 | barbed-end actin filament capping (GO:0051016) | 2.82215134 |
124 | regulation of early endosome to late endosome transport (GO:2000641) | 2.79592854 |
125 | activation of Rac GTPase activity (GO:0032863) | 2.73087268 |
126 | focal adhesion assembly (GO:0048041) | 2.72935975 |
127 | cell-substrate adherens junction assembly (GO:0007045) | 2.72935975 |
128 | basement membrane organization (GO:0071711) | 2.71756408 |
129 | detection of other organism (GO:0098543) | 2.69267722 |
130 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.68983156 |
131 | epoxygenase P450 pathway (GO:0019373) | 2.68963750 |
132 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.67496394 |
133 | pentose-phosphate shunt (GO:0006098) | 2.67298492 |
134 | negative regulation of fatty acid transport (GO:2000192) | 2.64511495 |
135 | NADH metabolic process (GO:0006734) | 2.64486155 |
136 | adherens junction assembly (GO:0034333) | 2.63627579 |
137 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.62618476 |
138 | apoptotic process involved in morphogenesis (GO:0060561) | 2.62199615 |
139 | stress fiber assembly (GO:0043149) | 2.61295471 |
140 | protein localization to endosome (GO:0036010) | 2.59965503 |
141 | regulation of extracellular matrix organization (GO:1903053) | 2.59128781 |
142 | cell volume homeostasis (GO:0006884) | 2.58931395 |
143 | positive regulation of extracellular matrix organization (GO:1903055) | 2.58193287 |
144 | positive regulation of histone deacetylation (GO:0031065) | 2.54045433 |
145 | maternal placenta development (GO:0001893) | 2.53778028 |
146 | cell-cell junction maintenance (GO:0045217) | 2.53423234 |
147 | positive regulation of protein dephosphorylation (GO:0035307) | 2.51584795 |
148 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.49735612 |
149 | positive regulation of receptor recycling (GO:0001921) | 2.49083160 |
150 | semaphorin-plexin signaling pathway (GO:0071526) | 2.47521046 |
151 | receptor recycling (GO:0001881) | 2.45979375 |
152 | positive thymic T cell selection (GO:0045059) | 2.45022934 |
153 | glucose catabolic process (GO:0006007) | 2.44404809 |
154 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.40298648 |
155 | negative regulation of cell killing (GO:0031342) | 2.40298648 |
156 | cell-substrate junction assembly (GO:0007044) | 2.40009521 |
157 | detection of external biotic stimulus (GO:0098581) | 2.37627825 |
158 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.37392449 |
159 | response to laminar fluid shear stress (GO:0034616) | 2.35938831 |
160 | activation of JUN kinase activity (GO:0007257) | 2.35267780 |
161 | atrioventricular valve morphogenesis (GO:0003181) | 2.34242335 |
162 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.32580844 |
163 | response to muramyl dipeptide (GO:0032495) | 2.31437238 |
164 | regulation of apoptotic cell clearance (GO:2000425) | 2.31346205 |
165 | modulation by symbiont of host cellular process (GO:0044068) | 2.31316958 |
166 | signal complex assembly (GO:0007172) | 2.30962049 |
167 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.29752109 |
168 | regulation of fatty acid biosynthetic process (GO:0042304) | 2.28642504 |
169 | thymic T cell selection (GO:0045061) | 2.27858856 |
170 | oxaloacetate metabolic process (GO:0006107) | 2.26631191 |
171 | creatine metabolic process (GO:0006600) | 2.26400952 |
172 | UV protection (GO:0009650) | 2.21024560 |
173 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.20995878 |
174 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.20277580 |
175 | actin filament polymerization (GO:0030041) | 2.20258275 |
176 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.19762476 |
177 | fructose metabolic process (GO:0006000) | 2.18713726 |
178 | activation of MAPKKK activity (GO:0000185) | 2.18676849 |
179 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.18259999 |
180 | germinal center formation (GO:0002467) | 2.18253984 |
181 | positive regulation of Rap GTPase activity (GO:0032854) | 2.18221598 |
182 | modulation by virus of host process (GO:0019054) | 2.17871039 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.94713596 |
2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.00548638 |
3 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.22408386 |
4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.84645836 |
5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.41135597 |
6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.55088316 |
7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.30716712 |
8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.63737995 |
9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.43847819 |
10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.69668771 |
11 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.59726101 |
12 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.34637337 |
13 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.08050006 |
14 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.91750844 |
15 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.90198464 |
16 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.87508208 |
17 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.85494808 |
18 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.84895778 |
19 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.77156825 |
20 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.62130861 |
21 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.61968597 |
22 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.55990478 |
23 | MAF_26560356_Chip-Seq_TH1_Human | 1.55499774 |
24 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.52577852 |
25 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.43889277 |
26 | MAF_26560356_Chip-Seq_TH2_Human | 1.39721382 |
27 | * CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.37626815 |
28 | GATA1_22025678_ChIP-Seq_K562_Human | 1.34807012 |
29 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.34162846 |
30 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.33609637 |
31 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.33263757 |
32 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.32155045 |
33 | UTX_26944678_Chip-Seq_JUKART_Human | 1.31814985 |
34 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.30797403 |
35 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.28025338 |
36 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.26831837 |
37 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.25352204 |
38 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.25078090 |
39 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.23370156 |
40 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.22736631 |
41 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.21733527 |
42 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.21603582 |
43 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.20779223 |
44 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.19954095 |
45 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.19879153 |
46 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.19841872 |
47 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.18196667 |
48 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.17842825 |
49 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.15844108 |
50 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15747249 |
51 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.15270550 |
52 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.15243723 |
53 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.15056389 |
54 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.14199989 |
55 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.13648800 |
56 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.12238142 |
57 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.12116540 |
58 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.08738550 |
59 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.08144351 |
60 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.07922574 |
61 | MYC_22102868_ChIP-Seq_BL_Human | 1.04873432 |
62 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.04128194 |
63 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.03995357 |
64 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.02394817 |
65 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.02119018 |
66 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.01987674 |
67 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.01943405 |
68 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.01442039 |
69 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.00988371 |
70 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.00632081 |
71 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.00434469 |
72 | GATA1_19941826_ChIP-Seq_K562_Human | 0.99925867 |
73 | SA1_27219007_Chip-Seq_Bcells_Human | 0.99763567 |
74 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.99488483 |
75 | P68_20966046_ChIP-Seq_HELA_Human | 0.99480972 |
76 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.99025403 |
77 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.98488558 |
78 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.97926972 |
79 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.96805463 |
80 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.96670900 |
81 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.95225852 |
82 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.95131572 |
83 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.94924137 |
84 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.90175057 |
85 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.89246166 |
86 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.89072533 |
87 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.88715883 |
88 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.87999039 |
89 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.87959553 |
90 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.87798579 |
91 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.87643015 |
92 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.86588428 |
93 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.85625176 |
94 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.85026763 |
95 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.84742626 |
96 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.84043965 |
97 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.83956236 |
98 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.83534654 |
99 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.82799781 |
100 | KDM2B_26808549_Chip-Seq_K562_Human | 0.81784983 |
101 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.80062943 |
102 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.80043373 |
103 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.78867903 |
104 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.78633408 |
105 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.78478687 |
106 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.78121819 |
107 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.76692621 |
108 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.76692621 |
109 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.76361707 |
110 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.76127397 |
111 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.74466353 |
112 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.74263981 |
113 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.74139432 |
114 | ATF3_27146783_Chip-Seq_COLON_Human | 0.73493189 |
115 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.72574896 |
116 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.71856749 |
117 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.71708584 |
118 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.70953362 |
119 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.69936534 |
120 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.69926695 |
121 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.69728890 |
122 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.69039874 |
123 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.68700557 |
124 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.68633990 |
125 | GATA2_19941826_ChIP-Seq_K562_Human | 0.67939554 |
126 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.67373053 |
127 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.67004471 |
128 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.66671983 |
129 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.66178914 |
130 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.66114739 |
131 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.65024122 |
132 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.65008613 |
133 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.64920543 |
134 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.64274553 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 7.67329646 |
2 | MP0005360_urolithiasis | 7.00463813 |
3 | MP0005365_abnormal_bile_salt | 5.70903837 |
4 | MP0005085_abnormal_gallbladder_physiolo | 5.61252573 |
5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.51517684 |
6 | MP0009840_abnormal_foam_cell | 3.83045807 |
7 | MP0003252_abnormal_bile_duct | 3.67632991 |
8 | MP0010329_abnormal_lipoprotein_level | 3.55769835 |
9 | MP0003806_abnormal_nucleotide_metabolis | 3.34793048 |
10 | MP0005083_abnormal_biliary_tract | 3.13854067 |
11 | MP0005332_abnormal_amino_acid | 2.80521368 |
12 | MP0003191_abnormal_cellular_cholesterol | 2.68745710 |
13 | MP0001666_abnormal_nutrient_absorption | 2.61146708 |
14 | MP0003195_calcinosis | 2.58709345 |
15 | MP0003172_abnormal_lysosome_physiology | 2.40605014 |
16 | MP0008438_abnormal_cutaneous_collagen | 2.32093828 |
17 | MP0005409_darkened_coat_color | 2.30876501 |
18 | MP0003436_decreased_susceptibility_to | 2.26415180 |
19 | MP0002118_abnormal_lipid_homeostasis | 2.22659424 |
20 | MP0000609_abnormal_liver_physiology | 2.20532882 |
21 | MP0003705_abnormal_hypodermis_morpholog | 2.09478203 |
22 | MP0001849_ear_inflammation | 2.08602408 |
23 | MP0008260_abnormal_autophagy | 2.01413915 |
24 | MP0003566_abnormal_cell_adhesion | 1.98144959 |
25 | MP0004019_abnormal_vitamin_homeostasis | 1.95385590 |
26 | MP0002138_abnormal_hepatobiliary_system | 1.86855338 |
27 | MP0005319_abnormal_enzyme/_coenzyme | 1.86559673 |
28 | MP0000751_myopathy | 1.83329487 |
29 | MP0005076_abnormal_cell_differentiation | 1.81278415 |
30 | MP0009278_abnormal_bone_marrow | 1.80343550 |
31 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.71729765 |
32 | MP0003279_aneurysm | 1.66048912 |
33 | MP0000678_abnormal_parathyroid_gland | 1.61224878 |
34 | MP0005670_abnormal_white_adipose | 1.60549779 |
35 | MP0003868_abnormal_feces_composition | 1.60305589 |
36 | MP0004130_abnormal_muscle_cell | 1.59384691 |
37 | MP0002132_abnormal_respiratory_system | 1.56625316 |
38 | MP0002249_abnormal_larynx_morphology | 1.54840505 |
39 | MP0001958_emphysema | 1.49738869 |
40 | MP0009643_abnormal_urine_homeostasis | 1.48856495 |
41 | MP0003091_abnormal_cell_migration | 1.45820475 |
42 | MP0003453_abnormal_keratinocyte_physiol | 1.45534822 |
43 | MP0002089_abnormal_postnatal_growth/wei | 1.35297896 |
44 | MP0004947_skin_inflammation | 1.31824748 |
45 | MP0000604_amyloidosis | 1.28566119 |
46 | MP0000858_altered_metastatic_potential | 1.26011759 |
47 | MP0005666_abnormal_adipose_tissue | 1.22873965 |
48 | MP0010234_abnormal_vibrissa_follicle | 1.21444998 |
49 | MP0003879_abnormal_hair_cell | 1.19937914 |
50 | MP0003329_amyloid_beta_deposits | 1.19185875 |
51 | MP0000598_abnormal_liver_morphology | 1.17613504 |
52 | MP0003763_abnormal_thymus_physiology | 1.16836236 |
53 | MP0004510_myositis | 1.15224064 |
54 | MP0002396_abnormal_hematopoietic_system | 1.15151848 |
55 | MP0005023_abnormal_wound_healing | 1.14003075 |
56 | MP0001764_abnormal_homeostasis | 1.13557778 |
57 | MP0000681_abnormal_thyroid_gland | 1.12580626 |
58 | MP0003045_fibrosis | 1.11876693 |
59 | MP0003183_abnormal_peptide_metabolism | 1.11532247 |
60 | MP0000685_abnormal_immune_system | 1.10059844 |
61 | MP0002933_joint_inflammation | 1.09952727 |
62 | MP0006036_abnormal_mitochondrial_physio | 1.09193202 |
63 | MP0005451_abnormal_body_composition | 1.07571806 |
64 | MP0003656_abnormal_erythrocyte_physiolo | 1.06901242 |
65 | MP0010155_abnormal_intestine_physiology | 1.06106715 |
66 | MP0001348_abnormal_lacrimal_gland | 1.05966193 |
67 | MP0002419_abnormal_innate_immunity | 1.04836199 |
68 | MP0002877_abnormal_melanocyte_morpholog | 1.04758454 |
69 | MP0002971_abnormal_brown_adipose | 1.03548928 |
70 | MP0001873_stomach_inflammation | 1.02880661 |
71 | MP0002078_abnormal_glucose_homeostasis | 1.01935379 |
72 | MP0009384_cardiac_valve_regurgitation | 1.00241768 |
73 | MP0002837_dystrophic_cardiac_calcinosis | 0.99190811 |
74 | MP0005535_abnormal_body_temperature | 0.98656305 |
75 | MP0004381_abnormal_hair_follicle | 0.95500547 |
76 | MP0004264_abnormal_extraembryonic_tissu | 0.94758715 |
77 | MP0004859_abnormal_synaptic_plasticity | 0.94443309 |
78 | MP0002998_abnormal_bone_remodeling | 0.94422458 |
79 | MP0005636_abnormal_mineral_homeostasis | 0.94392418 |
80 | MP0002254_reproductive_system_inflammat | 0.93568076 |
81 | MP0005025_abnormal_response_to | 0.93556127 |
82 | MP0001533_abnormal_skeleton_physiology | 0.93477945 |
83 | MP0004185_abnormal_adipocyte_glucose | 0.90867184 |
84 | MP0000013_abnormal_adipose_tissue | 0.90215546 |
85 | MP0001756_abnormal_urination | 0.88366668 |
86 | MP0009642_abnormal_blood_homeostasis | 0.88072117 |
87 | MP0000759_abnormal_skeletal_muscle | 0.87762090 |
88 | MP0003011_delayed_dark_adaptation | 0.87606616 |
89 | MP0008961_abnormal_basal_metabolism | 0.87457434 |
90 | MP0005220_abnormal_exocrine_pancreas | 0.87183481 |
91 | MP0004272_abnormal_basement_membrane | 0.86789604 |
92 | MP0003300_gastrointestinal_ulcer | 0.86509242 |
93 | MP0005334_abnormal_fat_pad | 0.85361647 |
94 | MP0002896_abnormal_bone_mineralization | 0.82234287 |
95 | MP0009763_increased_sensitivity_to | 0.82054246 |
96 | MP0010368_abnormal_lymphatic_system | 0.81729994 |
97 | MP0003186_abnormal_redox_activity | 0.81720905 |
98 | MP0003828_pulmonary_edema | 0.81196872 |
99 | MP0003075_altered_response_to | 0.80163461 |
100 | MP0004087_abnormal_muscle_fiber | 0.79505094 |
101 | MP0005375_adipose_tissue_phenotype | 0.79282638 |
102 | MP0000462_abnormal_digestive_system | 0.78849913 |
103 | MP0009780_abnormal_chondrocyte_physiolo | 0.77443697 |
104 | MP0005167_abnormal_blood-brain_barrier | 0.77392791 |
105 | MP0005165_increased_susceptibility_to | 0.77267318 |
106 | MP0008469_abnormal_protein_level | 0.77245508 |
107 | MP0005647_abnormal_sex_gland | 0.77056837 |
108 | MP0003634_abnormal_glial_cell | 0.76658500 |
109 | MP0003866_abnormal_defecation | 0.76251516 |
110 | MP0003690_abnormal_glial_cell | 0.76010269 |
111 | MP0000767_abnormal_smooth_muscle | 0.74721772 |
112 | MP0005387_immune_system_phenotype | 0.73933234 |
113 | MP0001790_abnormal_immune_system | 0.73933234 |
114 | MP0010630_abnormal_cardiac_muscle | 0.73124371 |
115 | MP0004233_abnormal_muscle_weight | 0.71955219 |
116 | MP0005448_abnormal_energy_balance | 0.71708530 |
117 | MP0005501_abnormal_skin_physiology | 0.70040861 |
118 | MP0005397_hematopoietic_system_phenotyp | 0.69488969 |
119 | MP0009764_decreased_sensitivity_to | 0.67834500 |
120 | MP0002822_catalepsy | 0.67226689 |
121 | MP0004043_abnormal_pH_regulation | 0.66002256 |
122 | MP0005084_abnormal_gallbladder_morpholo | 0.65078382 |
123 | MP0006035_abnormal_mitochondrial_morpho | 0.64112018 |
124 | MP0002136_abnormal_kidney_physiology | 0.63821557 |
125 | MP0008874_decreased_physiological_sensi | 0.60767919 |
126 | MP0005058_abnormal_lysosome_morphology | 0.59240116 |
127 | MP0005376_homeostasis/metabolism_phenot | 0.57968489 |
128 | MP0002928_abnormal_bile_duct | 0.57429083 |
129 | MP0002909_abnormal_adrenal_gland | 0.56544538 |
130 | MP0002970_abnormal_white_adipose | 0.55499282 |
131 | MP0009765_abnormal_xenobiotic_induced | 0.54999461 |
132 | MP0003638_abnormal_response/metabolism_ | 0.54861211 |
133 | MP0001765_abnormal_ion_homeostasis | 0.53402910 |
134 | MP0002269_muscular_atrophy | 0.52000370 |
135 | MP0002796_impaired_skin_barrier | 0.51874981 |
136 | MP0005166_decreased_susceptibility_to | 0.51636571 |
137 | MP0003953_abnormal_hormone_level | 0.51443730 |
138 | MP0001661_extended_life_span | 0.50583994 |
139 | MP0009672_abnormal_birth_weight | 0.50577449 |
140 | MP0005266_abnormal_metabolism | 0.50276899 |
141 | MP0005330_cardiomyopathy | 0.49649849 |
142 | MP0009115_abnormal_fat_cell | 0.48754792 |
143 | MP0001944_abnormal_pancreas_morphology | 0.48363043 |
144 | MP0005464_abnormal_platelet_physiology | 0.47772448 |
145 | MP0000639_abnormal_adrenal_gland | 0.47055323 |
146 | MP0000230_abnormal_systemic_arterial | 0.45023972 |
147 | MP0009697_abnormal_copulation | 0.44566562 |
148 | MP0000747_muscle_weakness | 0.44263110 |
149 | MP0003303_peritoneal_inflammation | 0.41725648 |
150 | MP0004858_abnormal_nervous_system | 0.41142660 |
151 | MP0008873_increased_physiological_sensi | 0.39953877 |
152 | MP0003959_abnormal_lean_body | 0.38709052 |
153 | MP0000249_abnormal_blood_vessel | 0.38512818 |
154 | MP0002168_other_aberrant_phenotype | 0.37510092 |
155 | MP0008872_abnormal_physiological_respon | 0.37460148 |
156 | MP0000003_abnormal_adipose_tissue | 0.37340733 |
157 | MP0002876_abnormal_thyroid_physiology | 0.35602514 |
158 | MP0002135_abnormal_kidney_morphology | 0.33531891 |
159 | MP0002060_abnormal_skin_morphology | 0.33504731 |
160 | MP0009053_abnormal_anal_canal | 0.33233838 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Deep venous thrombosis (HP:0002625) | 6.60961301 |
2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.49781137 |
3 | Intrahepatic cholestasis (HP:0001406) | 5.98607772 |
4 | Xanthomatosis (HP:0000991) | 5.83402072 |
5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.55776978 |
6 | Hypobetalipoproteinemia (HP:0003563) | 5.18079265 |
7 | Hyperlipoproteinemia (HP:0010980) | 5.01691519 |
8 | Complement deficiency (HP:0004431) | 4.75615125 |
9 | Prolonged partial thromboplastin time (HP:0003645) | 4.70535534 |
10 | Ketosis (HP:0001946) | 4.61891310 |
11 | Hyperammonemia (HP:0001987) | 4.54634384 |
12 | Hyperglycinuria (HP:0003108) | 4.18886864 |
13 | Hypoglycemic coma (HP:0001325) | 4.11664302 |
14 | Abnormality of glycine metabolism (HP:0010895) | 4.02471494 |
15 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.02471494 |
16 | Hypolipoproteinemia (HP:0010981) | 4.02381615 |
17 | Epidermoid cyst (HP:0200040) | 4.01500925 |
18 | Hyperglycinemia (HP:0002154) | 4.00945037 |
19 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.88429578 |
20 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.72850553 |
21 | Hypoalphalipoproteinemia (HP:0003233) | 3.69962073 |
22 | Abnormality of the common coagulation pathway (HP:0010990) | 3.69952357 |
23 | Ketoacidosis (HP:0001993) | 3.69421413 |
24 | Joint hemorrhage (HP:0005261) | 3.68714463 |
25 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.64961506 |
26 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.52571011 |
27 | Abnormality of complement system (HP:0005339) | 3.48175769 |
28 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.43655099 |
29 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.43002120 |
30 | Hypercholesterolemia (HP:0003124) | 3.28679612 |
31 | Delayed CNS myelination (HP:0002188) | 3.25909408 |
32 | Protrusio acetabuli (HP:0003179) | 3.22815558 |
33 | Abnormality of methionine metabolism (HP:0010901) | 3.20127455 |
34 | Fat malabsorption (HP:0002630) | 3.17030508 |
35 | Obstructive sleep apnea (HP:0002870) | 3.14208218 |
36 | Cerebral aneurysm (HP:0004944) | 3.05748852 |
37 | Abnormality of the intrinsic pathway (HP:0010989) | 3.01707040 |
38 | Mucopolysacchariduria (HP:0008155) | 2.97523873 |
39 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.97523873 |
40 | Gout (HP:0001997) | 2.96566694 |
41 | Hyperbilirubinemia (HP:0002904) | 2.93571020 |
42 | Distal upper limb amyotrophy (HP:0007149) | 2.82824342 |
43 | Upper limb amyotrophy (HP:0009129) | 2.82824342 |
44 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.82328522 |
45 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.82328522 |
46 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.82328522 |
47 | Cervical subluxation (HP:0003308) | 2.80833416 |
48 | Increased connective tissue (HP:0009025) | 2.80616716 |
49 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.79445976 |
50 | Dicarboxylic aciduria (HP:0003215) | 2.79445976 |
51 | Abnormality of purine metabolism (HP:0004352) | 2.71147417 |
52 | Abnormality of nucleobase metabolism (HP:0010932) | 2.70695447 |
53 | Late onset (HP:0003584) | 2.70099470 |
54 | Broad face (HP:0000283) | 2.70054156 |
55 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.69791508 |
56 | Premature rupture of membranes (HP:0001788) | 2.68062692 |
57 | Spastic diplegia (HP:0001264) | 2.66696377 |
58 | Hepatocellular carcinoma (HP:0001402) | 2.66119170 |
59 | Myocardial infarction (HP:0001658) | 2.62620963 |
60 | Metabolic acidosis (HP:0001942) | 2.61745902 |
61 | Skin nodule (HP:0200036) | 2.60893909 |
62 | Conjugated hyperbilirubinemia (HP:0002908) | 2.60434510 |
63 | Distal lower limb amyotrophy (HP:0008944) | 2.59423569 |
64 | Vertebral compression fractures (HP:0002953) | 2.57282726 |
65 | Neonatal onset (HP:0003623) | 2.56150912 |
66 | Increased variability in muscle fiber diameter (HP:0003557) | 2.56112620 |
67 | Abnormality of serum amino acid levels (HP:0003112) | 2.52222753 |
68 | Myopathic facies (HP:0002058) | 2.50334233 |
69 | Hyperacusis (HP:0010780) | 2.49412863 |
70 | Distal lower limb muscle weakness (HP:0009053) | 2.47464117 |
71 | Exercise-induced myalgia (HP:0003738) | 2.43174136 |
72 | Nasal polyposis (HP:0100582) | 2.42404858 |
73 | Abnormality of the nasal mucosa (HP:0000433) | 2.42267087 |
74 | Hypoglycemic seizures (HP:0002173) | 2.41420603 |
75 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.39827755 |
76 | Amyloidosis (HP:0011034) | 2.39098759 |
77 | Systemic lupus erythematosus (HP:0002725) | 2.38153962 |
78 | Cholecystitis (HP:0001082) | 2.37696561 |
79 | Abnormal gallbladder physiology (HP:0012438) | 2.37696561 |
80 | Cellulitis (HP:0100658) | 2.35676766 |
81 | Lethargy (HP:0001254) | 2.34072316 |
82 | Malnutrition (HP:0004395) | 2.33980191 |
83 | Thin bony cortex (HP:0002753) | 2.33441064 |
84 | Cholelithiasis (HP:0001081) | 2.32024877 |
85 | Achilles tendon contracture (HP:0001771) | 2.31897113 |
86 | Eczematoid dermatitis (HP:0000976) | 2.31430966 |
87 | Myoglobinuria (HP:0002913) | 2.28210268 |
88 | Abnormal gallbladder morphology (HP:0012437) | 2.27948480 |
89 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.27840330 |
90 | Spontaneous abortion (HP:0005268) | 2.27788482 |
91 | Dysostosis multiplex (HP:0000943) | 2.27373117 |
92 | Ulnar bowing (HP:0003031) | 2.25864984 |
93 | Stridor (HP:0010307) | 2.25676826 |
94 | Hand muscle atrophy (HP:0009130) | 2.23044778 |
95 | Atelectasis (HP:0100750) | 2.21679498 |
96 | Sensorimotor neuropathy (HP:0007141) | 2.21162308 |
97 | Esophageal varix (HP:0002040) | 2.20441879 |
98 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.19145618 |
99 | Polygenic inheritance (HP:0010982) | 2.18806632 |
100 | Steatorrhea (HP:0002570) | 2.18694511 |
101 | Vascular calcification (HP:0004934) | 2.17957606 |
102 | Irritability (HP:0000737) | 2.16145690 |
103 | Generalized aminoaciduria (HP:0002909) | 2.15821619 |
104 | Abnormality of the Achilles tendon (HP:0005109) | 2.14680418 |
105 | Mitral stenosis (HP:0001718) | 2.14359356 |
106 | Colitis (HP:0002583) | 2.13993746 |
107 | Hemorrhage of the eye (HP:0011885) | 2.09066120 |
108 | Asymmetric septal hypertrophy (HP:0001670) | 2.06746090 |
109 | Joint stiffness (HP:0001387) | 2.05597413 |
110 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.04948719 |
111 | Vomiting (HP:0002013) | 2.04391985 |
112 | Aneurysm (HP:0002617) | 2.02767558 |
113 | Cerebral edema (HP:0002181) | 2.01530309 |
114 | Fragile skin (HP:0001030) | 2.01281081 |
115 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.00763446 |
116 | Acanthocytosis (HP:0001927) | 2.00046799 |
117 | Glomerulonephritis (HP:0000099) | 1.99797943 |
118 | Turricephaly (HP:0000262) | 1.99720438 |
119 | Difficulty climbing stairs (HP:0003551) | 1.99296110 |
120 | Abnormal cartilage morphology (HP:0002763) | 1.98819208 |
121 | Flat acetabular roof (HP:0003180) | 1.98638700 |
122 | Hydroxyprolinuria (HP:0003080) | 1.97062636 |
123 | Abnormality of proline metabolism (HP:0010907) | 1.97062636 |
124 | Dilatation of the ascending aorta (HP:0005111) | 1.96856819 |
125 | Pancreatitis (HP:0001733) | 1.95267477 |
126 | Polycythemia (HP:0001901) | 1.94029340 |
127 | Cardiovascular calcification (HP:0011915) | 1.93984415 |
128 | Short nail (HP:0001799) | 1.93755595 |
129 | Blue sclerae (HP:0000592) | 1.91307732 |
130 | Shallow orbits (HP:0000586) | 1.89716866 |
131 | Back pain (HP:0003418) | 1.89664739 |
132 | Increased purine levels (HP:0004368) | 1.87871345 |
133 | Hyperuricemia (HP:0002149) | 1.87871345 |
134 | Easy fatigability (HP:0003388) | 1.87635581 |
135 | Mitral regurgitation (HP:0001653) | 1.86987412 |
136 | Supranuclear gaze palsy (HP:0000605) | 1.86792334 |
137 | Abnormality of the gallbladder (HP:0005264) | 1.86203944 |
138 | Ulnar deviation of the wrist (HP:0003049) | 1.85844554 |
139 | Metaphyseal cupping (HP:0003021) | 1.83780078 |
140 | Global brain atrophy (HP:0002283) | 1.83020818 |
141 | Biconcave vertebral bodies (HP:0004586) | 1.82717765 |
142 | Emphysema (HP:0002097) | 1.82267568 |
143 | Ankle clonus (HP:0011448) | 1.81812160 |
144 | Hypertriglyceridemia (HP:0002155) | 1.81231344 |
145 | Thrombophlebitis (HP:0004418) | 1.80696120 |
146 | Gingivitis (HP:0000230) | 1.80507288 |
147 | Lymphangioma (HP:0100764) | 1.80197180 |
148 | Enlarged kidneys (HP:0000105) | 1.80179077 |
149 | Nephrolithiasis (HP:0000787) | 1.79979281 |
150 | Growth hormone excess (HP:0000845) | 1.79911273 |
151 | Bulbar palsy (HP:0001283) | 1.79180021 |
152 | Alkalosis (HP:0001948) | 1.79126230 |
153 | Gingival bleeding (HP:0000225) | 1.78791881 |
154 | Cerebral inclusion bodies (HP:0100314) | 1.78684447 |
155 | Status epilepticus (HP:0002133) | 1.77574825 |
156 | Neurofibrillary tangles (HP:0002185) | 1.77558280 |
157 | Interstitial pulmonary disease (HP:0006530) | 1.76938098 |
158 | Death in childhood (HP:0003819) | 1.76503746 |
159 | Spinal rigidity (HP:0003306) | 1.76090750 |
160 | Reticulocytosis (HP:0001923) | 1.76078805 |
161 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.75260004 |
162 | Stroke (HP:0001297) | 1.74004139 |
163 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.73925056 |
164 | Type 1 muscle fiber predominance (HP:0003803) | 1.73164633 |
165 | Disproportionate tall stature (HP:0001519) | 1.72825282 |
166 | Gastrointestinal inflammation (HP:0004386) | 1.72474992 |
167 | Lower limb amyotrophy (HP:0007210) | 1.70839105 |
168 | Gastrointestinal stroma tumor (HP:0100723) | 1.70734396 |
169 | Purpura (HP:0000979) | 1.69908200 |
170 | Arterial tortuosity (HP:0005116) | 1.67697338 |
171 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.65871600 |
172 | Increased IgE level (HP:0003212) | 1.65776432 |
173 | Hyporeflexia of lower limbs (HP:0002600) | 1.65446756 |
174 | Bronchomalacia (HP:0002780) | 1.64356945 |
175 | J-shaped sella turcica (HP:0002680) | 1.64049522 |
176 | Atrophic scars (HP:0001075) | 1.63594443 |
177 | Vascular tortuosity (HP:0004948) | 1.59186243 |
178 | Acanthosis nigricans (HP:0000956) | 1.58521547 |
179 | Abnormality of macrophages (HP:0004311) | 1.57667439 |
180 | Abnormality of the acetabulum (HP:0003170) | 1.56347923 |
181 | Gastrointestinal dysmotility (HP:0002579) | 1.56108361 |
182 | Osteolytic defects of the hand bones (HP:0009699) | 1.55622292 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BCKDK | 5.01152226 |
2 | TRIB3 | 4.93384325 |
3 | ERN1 | 4.78022087 |
4 | PKN2 | 3.78265020 |
5 | PRPF4B | 3.47753977 |
6 | SIK1 | 3.42455141 |
7 | FGFR4 | 3.28388553 |
8 | SMG1 | 3.22409069 |
9 | MAP3K10 | 2.64305196 |
10 | INSRR | 2.23623313 |
11 | PTK6 | 2.10104123 |
12 | RIPK1 | 2.04282002 |
13 | EEF2K | 1.92500716 |
14 | RIPK4 | 1.84689285 |
15 | EPHA2 | 1.83909682 |
16 | MAP3K7 | 1.52476246 |
17 | CAMK1D | 1.45117340 |
18 | FLT3 | 1.42980621 |
19 | DAPK2 | 1.42057862 |
20 | ICK | 1.41311950 |
21 | TNK2 | 1.40072372 |
22 | TAOK3 | 1.33854598 |
23 | GRK6 | 1.32754290 |
24 | CAMK1G | 1.24787853 |
25 | MAPK11 | 1.23066537 |
26 | MAP2K4 | 1.23036770 |
27 | TAOK2 | 1.18217047 |
28 | LRRK2 | 1.14464281 |
29 | TYK2 | 1.14125084 |
30 | MAP3K3 | 1.13991035 |
31 | IRAK3 | 1.12576941 |
32 | FGFR2 | 1.12380960 |
33 | TESK1 | 1.11622313 |
34 | MAP3K6 | 1.11316378 |
35 | KSR2 | 1.08764695 |
36 | MAP4K1 | 1.04641967 |
37 | EPHB1 | 1.02015798 |
38 | CDK12 | 1.01725008 |
39 | JAK2 | 0.99240484 |
40 | MST1R | 0.99080261 |
41 | CDC42BPA | 0.97409472 |
42 | DYRK1B | 0.95700646 |
43 | PDGFRA | 0.95162869 |
44 | MAP2K3 | 0.93497341 |
45 | TTN | 0.92776588 |
46 | RET | 0.92605275 |
47 | MAP3K9 | 0.86094123 |
48 | PINK1 | 0.85032454 |
49 | PRKAA2 | 0.84973141 |
50 | PRKD3 | 0.84145105 |
51 | TGFBR2 | 0.82825498 |
52 | TBK1 | 0.82397265 |
53 | PTK2 | 0.81857257 |
54 | PDK4 | 0.80292037 |
55 | PDK3 | 0.80292037 |
56 | MAP3K13 | 0.80206712 |
57 | JAK1 | 0.77752399 |
58 | CAMKK1 | 0.77459417 |
59 | BLK | 0.76137473 |
60 | PDPK1 | 0.76104013 |
61 | MTOR | 0.76028026 |
62 | HIPK2 | 0.75555351 |
63 | TESK2 | 0.74045792 |
64 | MET | 0.73599267 |
65 | MAP2K2 | 0.71839368 |
66 | MAP3K1 | 0.71102521 |
67 | KDR | 0.71033586 |
68 | ERBB4 | 0.69843720 |
69 | RPS6KC1 | 0.67124674 |
70 | RPS6KL1 | 0.67124674 |
71 | IRAK4 | 0.66924797 |
72 | SIK2 | 0.65874294 |
73 | MAPK12 | 0.65854707 |
74 | FES | 0.65737902 |
75 | WNK4 | 0.64197744 |
76 | LMTK2 | 0.63457152 |
77 | PDK1 | 0.63161071 |
78 | PRKCH | 0.63106413 |
79 | BMX | 0.62922496 |
80 | PRKG2 | 0.62839810 |
81 | NME2 | 0.61641132 |
82 | TYRO3 | 0.61321754 |
83 | MAP3K11 | 0.61196620 |
84 | PRKD1 | 0.61059874 |
85 | PIK3CG | 0.60146349 |
86 | PAK4 | 0.60028834 |
87 | CDK6 | 0.59867442 |
88 | HCK | 0.59675827 |
89 | ERBB2 | 0.59589308 |
90 | MAP3K2 | 0.59477191 |
91 | PRKAA1 | 0.59246139 |
92 | JAK3 | 0.58000762 |
93 | TIE1 | 0.57855504 |
94 | MAPK15 | 0.56874298 |
95 | CSF1R | 0.55332474 |
96 | MAPK4 | 0.55246129 |
97 | MAPK7 | 0.55159410 |
98 | PRKCZ | 0.54190181 |
99 | PHKG1 | 0.52477212 |
100 | PHKG2 | 0.52477212 |
101 | ABL2 | 0.52200336 |
102 | TAOK1 | 0.50616879 |
103 | CAMK4 | 0.50607816 |
104 | ZAP70 | 0.50283736 |
105 | GSK3A | 0.47885361 |
106 | MAP3K8 | 0.46727786 |
107 | FGFR3 | 0.46559842 |
108 | PRKACG | 0.45324661 |
109 | RPS6KA6 | 0.43487935 |
110 | LATS1 | 0.42771945 |
111 | MAP3K14 | 0.42709858 |
112 | MAPKAPK3 | 0.42130449 |
113 | MAP2K6 | 0.41805239 |
114 | CSK | 0.41084263 |
115 | CDK4 | 0.40969645 |
116 | BTK | 0.40819029 |
117 | DDR2 | 0.40645520 |
118 | SGK3 | 0.40164054 |
119 | PDGFRB | 0.39828079 |
120 | NTRK3 | 0.39683164 |
121 | MARK2 | 0.39582832 |
122 | PAK2 | 0.38951650 |
123 | IRAK2 | 0.38394025 |
124 | MAP2K1 | 0.38049596 |
125 | SIK3 | 0.38001547 |
126 | STK38 | 0.37468961 |
127 | ARAF | 0.36066734 |
128 | NTRK1 | 0.32545359 |
129 | PAK3 | 0.32362941 |
130 | DAPK3 | 0.32327465 |
131 | PRKD2 | 0.32076843 |
132 | STK11 | 0.31585493 |
133 | FYN | 0.30639140 |
134 | RPS6KA2 | 0.29809351 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.08464143 |
2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.88885699 |
3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.39512015 |
4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.15613887 |
5 | Other glycan degradation_Homo sapiens_hsa00511 | 3.02937993 |
6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.02072287 |
7 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.81054535 |
8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.73781420 |
9 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.63643314 |
10 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.59704131 |
11 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.52172864 |
12 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.32135485 |
13 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.28610240 |
14 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.25885413 |
15 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.21596117 |
16 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.18724870 |
17 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.12792442 |
18 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.08395882 |
19 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.97887041 |
20 | * Peroxisome_Homo sapiens_hsa04146 | 1.93941928 |
21 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.75078810 |
22 | Bile secretion_Homo sapiens_hsa04976 | 1.67869684 |
23 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.67180637 |
24 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.66988546 |
25 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.65444194 |
26 | Histidine metabolism_Homo sapiens_hsa00340 | 1.59736924 |
27 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.58918407 |
28 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.55087429 |
29 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.53270498 |
30 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.53034131 |
31 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.51158562 |
32 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.50672372 |
33 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.46205594 |
34 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.45483787 |
35 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.44840605 |
36 | Carbon metabolism_Homo sapiens_hsa01200 | 1.43415668 |
37 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.41148280 |
38 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.40266404 |
39 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.39559305 |
40 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.38689462 |
41 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.38031173 |
42 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.37639214 |
43 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.36079123 |
44 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.35291878 |
45 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.29104707 |
46 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.28465323 |
47 | Retinol metabolism_Homo sapiens_hsa00830 | 1.24386757 |
48 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.23009210 |
49 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.22613653 |
50 | ABC transporters_Homo sapiens_hsa02010 | 1.21744957 |
51 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.21669029 |
52 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.20985071 |
53 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.19564287 |
54 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.18158372 |
55 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.16286781 |
56 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.14327402 |
57 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.14209957 |
58 | Sulfur relay system_Homo sapiens_hsa04122 | 1.09733783 |
59 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.05354397 |
60 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.02842618 |
61 | Lysine degradation_Homo sapiens_hsa00310 | 1.02272638 |
62 | Endometrial cancer_Homo sapiens_hsa05213 | 1.02258776 |
63 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.01962072 |
64 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.01729910 |
65 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.00848222 |
66 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.00658443 |
67 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.99747215 |
68 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.99590602 |
69 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.97761146 |
70 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.96930113 |
71 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.96450517 |
72 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.96141274 |
73 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.94338369 |
74 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.93880577 |
75 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.92262915 |
76 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.88899220 |
77 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.87390363 |
78 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.85843117 |
79 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.85582469 |
80 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.85056888 |
81 | Focal adhesion_Homo sapiens_hsa04510 | 0.84141106 |
82 | Leishmaniasis_Homo sapiens_hsa05140 | 0.83620086 |
83 | Hepatitis C_Homo sapiens_hsa05160 | 0.82539119 |
84 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.81458775 |
85 | Glioma_Homo sapiens_hsa05214 | 0.80431636 |
86 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.79126010 |
87 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.77368029 |
88 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.76655264 |
89 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.75005568 |
90 | Endocytosis_Homo sapiens_hsa04144 | 0.74046638 |
91 | Long-term potentiation_Homo sapiens_hsa04720 | 0.72531274 |
92 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.71937541 |
93 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.71708393 |
94 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.71252757 |
95 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.68408722 |
96 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.67753636 |
97 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.64276046 |
98 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.62382512 |
99 | Insulin resistance_Homo sapiens_hsa04931 | 0.61296244 |
100 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.59097605 |
101 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.59042968 |
102 | Thyroid cancer_Homo sapiens_hsa05216 | 0.57609523 |
103 | Platelet activation_Homo sapiens_hsa04611 | 0.56823333 |
104 | Influenza A_Homo sapiens_hsa05164 | 0.54398835 |
105 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.52847569 |
106 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.51139172 |
107 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.49900952 |
108 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.49728231 |
109 | Tuberculosis_Homo sapiens_hsa05152 | 0.49515697 |
110 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.49250219 |
111 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.48845400 |
112 | Hepatitis B_Homo sapiens_hsa05161 | 0.48290834 |
113 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.46347314 |
114 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.45645807 |
115 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.45225146 |
116 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.43897660 |
117 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.43049164 |
118 | Prion diseases_Homo sapiens_hsa05020 | 0.40623218 |
119 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.36313167 |
120 | Galactose metabolism_Homo sapiens_hsa00052 | 0.35868638 |
121 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.34006134 |
122 | Metabolic pathways_Homo sapiens_hsa01100 | 0.33655190 |
123 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.33182011 |
124 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.31399961 |
125 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.23971159 |
126 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.23877223 |
127 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.19324872 |
128 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.15326796 |
129 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.08216283 |
130 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.06083079 |
131 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.06055572 |
132 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.04513701 |
133 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.02969656 |
134 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.02469092 |
135 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.00874914 |
136 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.00583710 |
137 | Acute myeloid leukemia_Homo sapiens_hsa05221 | -0.1430044 |
138 | Lysosome_Homo sapiens_hsa04142 | -0.1390313 |
139 | Non-small cell lung cancer_Homo sapiens_hsa05223 | -0.0958696 |
140 | Amoebiasis_Homo sapiens_hsa05146 | -0.0911365 |
141 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | -0.0836888 |
142 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | -0.0792155 |
143 | Bladder cancer_Homo sapiens_hsa05219 | -0.0775671 |
144 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | -0.0607968 |
145 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.0606653 |
146 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0538272 |
147 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0399417 |
148 | Linoleic acid metabolism_Homo sapiens_hsa00591 | -0.0386054 |
149 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.0294872 |